What is VRDN's dilution risk score?

VRDN has a latest available DilutionScore record of 52/100, categorized as high dilution risk by the DilutionWatch scoring model. DilutionWatch displays SEC filing and dilution indicators for VRDN, including shelf registrations, ATM offerings, warrant exercises, PIPE deals, and reverse split signals when detected in source data.

What SEC filings does DilutionWatch track for VRDN?

DilutionWatch tracks 25 SEC filing types for VRDN including S-3 shelf registrations, 424B prospectuses (ATM offerings), S-1 registration statements, 8-K material events, warrant exercise notices, convertible note agreements, and Form 4 insider transactions. Alerts are delivered via email within minutes of a filing appearing on EDGAR.

How does stock dilution affect VRDN shareholders?

Stock dilution occurs when a company issues new shares, reducing the ownership percentage of existing shareholders. For VRDN, common dilution events include at-the-market (ATM) stock offerings, shelf registration drawdowns, warrant exercises, and convertible note conversions. Each event increases the share count and can pressure the stock price lower.

Is DilutionWatch free for VRDN tracking?

DilutionWatch provides a free tier that shows DilutionScores and basic filing history for VRDN. Premium plans ($19.95/month Basic, $39.95/month Premium) unlock real-time email alerts, the full Pulse™ feed, advanced dilution forecasts, and access to all 10,000+ tracked tickers.

VRDN Dilution Risk Score: 52/100 (HIGH)

Score Breakdown

📋 Offering Ability

52

💰 Cash Runway

65

📊 Float Risk

12

⚠️ Warrant Exposure

30

🔄 Convertible Debt

35

Dilution Forecast

☀️

Clear

No significant dilution signals

model est. 15%

💰 Capital Raise model 15%

• Under 12 months cash (6mo)

📜 Warrant Exercise model 15%

• Warrant overhang: 6.7% of shares outstanding

🔁 Convertible Conversion model 15%

• Convertible debt present: 12.4% potential dilution

🔔 Track VRDN — Get forecast alerts →

Market Data

Market Cap$1.95B

Shares Outstanding113.29M

Float103.02M

Cash$169.43M

Debt$29.32M

Short InterestN/A

Institutional Holdings

QoQ: ↑ 16.6% shares (2026Q1 vs prior)

227 institutional holders · 126.67M shares

#1 FMR LLC 15.38M shares

#2 VANGUARD CAPITAL MANAGEMENT LLC 8.33M shares

#3 BlackRock, Inc. 7.83M shares

+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest19.23M

Days to Cover11.3

% of Float18.7%

FINRA data as of Jul 31, 2026

Insider Buy/Sell Ratio

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2026-06-30

xbrl XBRL WARRANT 2025-12-31

4 INSIDER TRANSACTION 2026-07-02

Full SEC filing analysis available with free account →

Recent News

No recent news

Factual VRDN Dilution Snapshot

Viridian Therapeutics, Inc. (VRDN) has a DilutionScore of 52/100, rated High dilution risk. Score date: August 28, 2026.

Stored outstanding warrants: 7.5M.
Recent SEC activity tracked for VRDN: 4 on 2026-07-02; 4 on 2026-07-02; 4 on 2026-07-02.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.